Ursula Oberkichner

Works (3)

Updated: July 5th, 2023 15:48

2011 article

Metaflumizone–amitraz (Promeris)‐associated pustular acantholytic dermatitis in 22 dogs: evidence suggests contact drug‐triggered pemphigus foliaceus

Oberkirchner, U., Linder, K. E., Dunston, S., Bizikova, P., & Olivry, T. (2011, March 21). Veterinary Dermatology, Vol. 22, pp. 436–448.

By: U. Oberkirchner n, K. Linder n, S. Dunston*, P. Bizikova*  & T. Olivry n 

Contributors: U. Oberkirchner n, K. Linder n, S. Dunston*, P. Bizikova*  & T. Olivry n 

MeSH headings : Administration, Topical; Animals; Apoptosis / drug effects; Apoptosis / physiology; Caspase 3 / metabolism; Dog Diseases / chemically induced; Dog Diseases / drug therapy; Dog Diseases / immunology; Dog Diseases / pathology; Dogs; Female; Immunosuppressive Agents / administration & dosage; Immunosuppressive Agents / therapeutic use; Insecticides / administration & dosage; Insecticides / adverse effects; Keratinocytes / enzymology; Male; Pemphigus / chemically induced; Pemphigus / drug therapy; Pemphigus / veterinary; Semicarbazones / administration & dosage; Semicarbazones / adverse effects; Skin / pathology; Toluidines / administration & dosage; Toluidines / adverse effects
topics (OpenAlex): Autoimmune Bullous Skin Diseases; Nail Diseases and Treatments; Infectious Diseases and Mycology
TL;DR: PD has the potential of triggering a variant of PF that resembles spontaneously occurring autoimmune PF at clinical, morphological, immunological and treatment outcome levels. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Sources: Web Of Science, ORCID, NC State University Libraries
Added: August 6, 2018

2011 article

Successful treatment of a novel generalized variant of canine discoid lupus erythematosus with oral hydroxychloroquine

Oberkirchner, U., Linder, K. E., & Olivry, T. (2011, July 1). Veterinary Dermatology, Vol. 23, pp. 65–16.

By: U. Oberkirchner n, K. Linder n & T. Olivry n 

Contributors: U. Oberkirchner n, K. Linder n & T. Olivry n 

MeSH headings : Administration, Oral; Animals; Antirheumatic Agents / therapeutic use; Dog Diseases / drug therapy; Dog Diseases / pathology; Dogs; Female; Hydroxychloroquine / therapeutic use; Lupus Erythematosus, Discoid / drug therapy; Lupus Erythematosus, Discoid / pathology; Lupus Erythematosus, Discoid / veterinary; Treatment Outcome
topics (OpenAlex): Systemic Lupus Erythematosus Research; Herpesvirus Infections and Treatments; T-cell and B-cell Immunology
TL;DR: A generalized variant of canine DLE successfully treated with the antimalarial immunomodulator hydroxychloroquine (HCQ) mirrored the generalized discoid variant of chronic cutaneous lupus erythematosus of humans, and the apparent benefit of HCQ, its safety and low cost warrant future investigations of its use for treatment of canine cutaneouslupus variants. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Sources: Web Of Science, ORCID, NC State University Libraries
Added: August 6, 2018

2010 article

Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide

Oberkirchner, U., Linder, K. E., Zadrozny, L., & Olivry, T. (2010, May 27). Veterinary Dermatology, Vol. 21, pp. 510–516.

By: U. Oberkirchner n, K. Linder n, L. Zadrozny n & T. Olivry n 

Contributors: U. Oberkirchner n, K. Linder n, L. Zadrozny n & T. Olivry n 

MeSH headings : Animals; Anorexia / chemically induced; Anorexia / veterinary; Antineoplastic Agents, Hormonal / administration & dosage; Antineoplastic Agents, Hormonal / adverse effects; Antineoplastic Agents, Hormonal / therapeutic use; Dog Diseases / drug therapy; Dogs; Dose-Response Relationship, Drug; Glucagonoma / complications; Glucagonoma / pathology; Glucagonoma / veterinary; Lymph Nodes / pathology; Male; Necrolytic Migratory Erythema / drug therapy; Necrolytic Migratory Erythema / veterinary; Octreotide / administration & dosage; Octreotide / adverse effects; Octreotide / therapeutic use; Pancreatic Neoplasms / complications; Pancreatic Neoplasms / veterinary; Paraneoplastic Syndromes / pathology; Paraneoplastic Syndromes / veterinary
topics (OpenAlex): Neuroendocrine Tumor Research Advances; Neuroblastoma Research and Treatments; Lung Cancer Research Studies
TL;DR: Subcutaneous octreotide injections were beneficial in this dog with glucagonoma-associated NME and this somatostatin analogue could be a valuable option to treat canine patients with non-resectable or relapsing pancreatic glucagonomas- associated NME. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
Sources: Web Of Science, ORCID, NC State University Libraries
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2026) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.